{"title":"2013-2017年ESI数据库中国内临床医学高引用论文的研究与分析","authors":"Mingrong Dong","doi":"10.3760/CMA.J.ISSN.1006-1924.2019.04.014","DOIUrl":null,"url":null,"abstract":"Objective \nTo investigate and analyze the highly cited papers of clinical medicine by Chinese authors in recent 5 years based on the ESI database, and to understand the publication condition of highly cited papers of clinical medicine in China. \n \n \nMethods \nWe retrieved the domestic highly-cited papers from the ESI database from 2013 to 2017 by computer, and analyzed the regional distribution, citation frequency, research institutions, research fields, fund sources, paper types, journal distribution and subject terms. \n \n \nResults \nA total number of 487 highly cited clinical papers were included in the study. About 50% of the authors were from Shanghai, Beijing, Jiangsu and Guangdong province, which mainly distributed in major research institutes nationwide. During the year 2014 to 2016, there were about 110 highly cited papers per year. Cancer research was the main concern to scientists all over the world. \n \n \nConclusions \nThe clinical research in China is still at an unbalanced and uncoordinated level of development. Research institutions should grasp the hot spots of scientific research, increase research invest, track scientific research frontiers and expand their influence. \n \n \nKey words: \nEssential Science Indicators database; Chinese highly cited papers; Clinical medicine","PeriodicalId":59555,"journal":{"name":"中华医学科研管理杂志","volume":"32 1","pages":"298-302"},"PeriodicalIF":0.0000,"publicationDate":"2019-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Research and analysis of domestic highly cited papers of clinical medicine in ESI database during 2013-2017\",\"authors\":\"Mingrong Dong\",\"doi\":\"10.3760/CMA.J.ISSN.1006-1924.2019.04.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nTo investigate and analyze the highly cited papers of clinical medicine by Chinese authors in recent 5 years based on the ESI database, and to understand the publication condition of highly cited papers of clinical medicine in China. \\n \\n \\nMethods \\nWe retrieved the domestic highly-cited papers from the ESI database from 2013 to 2017 by computer, and analyzed the regional distribution, citation frequency, research institutions, research fields, fund sources, paper types, journal distribution and subject terms. \\n \\n \\nResults \\nA total number of 487 highly cited clinical papers were included in the study. About 50% of the authors were from Shanghai, Beijing, Jiangsu and Guangdong province, which mainly distributed in major research institutes nationwide. During the year 2014 to 2016, there were about 110 highly cited papers per year. Cancer research was the main concern to scientists all over the world. \\n \\n \\nConclusions \\nThe clinical research in China is still at an unbalanced and uncoordinated level of development. Research institutions should grasp the hot spots of scientific research, increase research invest, track scientific research frontiers and expand their influence. \\n \\n \\nKey words: \\nEssential Science Indicators database; Chinese highly cited papers; Clinical medicine\",\"PeriodicalId\":59555,\"journal\":{\"name\":\"中华医学科研管理杂志\",\"volume\":\"32 1\",\"pages\":\"298-302\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华医学科研管理杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1006-1924.2019.04.014\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华医学科研管理杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1006-1924.2019.04.014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Research and analysis of domestic highly cited papers of clinical medicine in ESI database during 2013-2017
Objective
To investigate and analyze the highly cited papers of clinical medicine by Chinese authors in recent 5 years based on the ESI database, and to understand the publication condition of highly cited papers of clinical medicine in China.
Methods
We retrieved the domestic highly-cited papers from the ESI database from 2013 to 2017 by computer, and analyzed the regional distribution, citation frequency, research institutions, research fields, fund sources, paper types, journal distribution and subject terms.
Results
A total number of 487 highly cited clinical papers were included in the study. About 50% of the authors were from Shanghai, Beijing, Jiangsu and Guangdong province, which mainly distributed in major research institutes nationwide. During the year 2014 to 2016, there were about 110 highly cited papers per year. Cancer research was the main concern to scientists all over the world.
Conclusions
The clinical research in China is still at an unbalanced and uncoordinated level of development. Research institutions should grasp the hot spots of scientific research, increase research invest, track scientific research frontiers and expand their influence.
Key words:
Essential Science Indicators database; Chinese highly cited papers; Clinical medicine
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
